Subgroup size | Age (<) | FFbHR (<) (0 to 100; 100 = best) | SF-12/36 PCS (<) (0 to 100; 100 = best) | SF-12/36 MCS (<) (0 to 100; 100 = best) | Treatment effect |
---|---|---|---|---|---|
0.001 | 37 | 29.17 | 33.62 | 28.93 | 91.29 |
0.102 | 91 | 29.17 | 67.75 | 56.82 | 16.79 |
0.200 | 54 | 54.17 | 43.62 | 72.11 | 13.74 |
0.308 | 62 | 54.17 | 67.75 | 72.11 | 12.72 |
0.400 | 62 | 70.83 | 40.45 | 60.35 | 11.32 |
0.509 | 67 | 62.50 | 67.75 | 72.11 | 10.36 |
0.602 | 91 | 75.00 | 40.45 | 60.35 | 9.96 |
0.702 | 91 | 75.00 | 47.59 | 60.35 | 9.14 |
0.808 | 91 | 100.00 | 47.59 | 60.35 | 8.59 |
0.906 | 91 | 100.00 | 47.59 | 72.11 | 8.47 |